Review
Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration
- PMID: 20739
Item in Clipboard
Review
Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration
Acta Med Scand Suppl.
1977.
No abstract available
Similar articles
-
Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma.Drugs. 1973;6(5):324-32. doi: 10.2165/00003495-197306050-00002. Drugs. 1973. PMID: 4150783 No abstract available.
-
Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.J Asthma. 1996;33(6):407-15. doi: 10.3109/02770909609068185. J Asthma. 1996. PMID: 8968295 Clinical Trial.
-
[Treatment of bronchial asthma].Klin Med (Mosk). 1974 Dec;52(12):16-21. Klin Med (Mosk). 1974. PMID: 4155460 Review. Russian. No abstract available.
-
Comparison of terbutaline and salebutamol aerosols in patients with bronchial asthma.Int J Clin Pharmacol Biopharm. 1978 Jul;16(7):310-2. Int J Clin Pharmacol Biopharm. 1978. PMID: 352973 Clinical Trial.
-
Tolerance to beta-agonists.Bull Eur Physiopathol Respir. 1985 Sep-Oct;21(5):1s-5s. Bull Eur Physiopathol Respir. 1985. PMID: 2865988 Review. English, French. No abstract available.
Cited by
-
Adverse reactions to beta 2-agonist bronchodilators.Med Toxicol. 1986 Jul-Aug;1(4):286-99. doi: 10.1007/BF03259844. Med Toxicol. 1986. PMID: 2878344 Review.
-
Anti-asthmatic effect of pitavastatin through aerosol inhalation is associated with CD4+ CD25+ Foxp3+ T cells in an asthma mouse model.Sci Rep. 2017 Jul 20;7(1):6084. doi: 10.1038/s41598-017-06476-6. Sci Rep. 2017. PMID: 28729731 Free PMC article.